-
Pre-Open Stock Movers 01/12: (TBIO) (STRP) (HSGX) Higher; (DRWI) (MYOS) (KOS) Lower (more...)
-
Trump's corporate tax holiday could spur pharma M&A
-
Pfizer boosts cancer drug roster with $14 billion Medivation deal
-
Payrolls power Wall Street to record high
-
Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee
-
Streetinsider.com's Hot Lunchtime Reads 7/1: (ARRS) (MRK) (SWKS) (TPLM)
-
U.S. corporations to report best and worst of times
-
Notable Analyst Rating Changes 12/1: (NOK) (TERP) (MRK) Upgraded; (ADRO) (REXX) (CMI) Downgraded
-
Merck (MRK), Cubist (CBST) Deal Likely to Go Ahead Despite Unfavorable Litigation, Says RBC
-
Merck (MRK) Data Unimpressive, Removes Overhang for Gilead Sciences (GILD), Says RBC
-
Gilead (GILD) Should Acquire Intercept (ICPT), Says RBC
-
Market Wrap: Icahn Sees Deal in Family Dollar; Facebook Gets PayPal Exec; Merger Monday!
-
Notable Mergers and Acquisitions of the Day 11/15: (KMB) (RCKB)/(UBNK) (AKRX) (BTH)
-
Pre-Open Stock Movers 8/13: (OSIR) (DGIT) (ARTX) Higher; (OCZ) (OWW) (NAT) Lower (more...)
-
Notable Analyst Rating Changes 11/29: (LCC) (RIMM) (DNR) Upgraded; (PPL) (NBR) (ZION) Downgraded
-
Vertex (VRTX) Shares Rise as Wells Fargo, RBC Defend Amid Incivek Concerns
-
Notable Analyst Rating Changes 08/09: (WFC) (S) (MRK) Upgraded; (ENOC) (STXS) (LLNW) Downgraded
-
Notable Analyst Rating Changes 06/04: JOYG, MRK, ORCL, SGMS Upgraded; INFA, HYC, NLC, STP Downgraded
-
Notable Analyst Rating Changes 3/13: HIBB, FWLT, HAL Upgraded; EMC, NOV, BJS, DKS Downgraded
-
David Moenning's Daily State of the Markets: 3/13
-
Notable Analyst Rating Changes 10/17: UNH, KFT, M, MRK Upgraded; SPWRA, ARM, FCX, MNST Downgraded
-
Notable Analyst Rating Changes 7/18: C, SPWR, XTO, UAUA Upgraded; VCLK, GILD, MER, BBY Downgraded
-
Pre-Open Movers: IBM (IBM) Lifts Tech On Positive Preannouncement, A.S.V. (ASVI) Up On Buyout; Harman (HAR) Sinks On Outlook